Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2009 3
2010 1
2011 1
2012 2
2013 4
2014 7
2015 4
2016 5
2017 4
2018 11
2019 10
2020 12
2021 7
2022 11
2023 7
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

78 results

Results by year

Filters applied: . Clear all
Page 1
Experiences of persons with multiple sclerosis with the Covid-19 vaccination: A cross-sectional study of the Swiss Multiple Sclerosis Registry.
Stanikić M, Twomey E, Puhan MA, Kamm CP, Salmen A, Ajdacic-Gross V, Zecca C, Gobbi C, von Wyl V; Swiss Multiple Sclerosis Registry. Stanikić M, et al. Among authors: kamm cp. Mult Scler Relat Disord. 2023 Jun;74:104707. doi: 10.1016/j.msard.2023.104707. Epub 2023 Apr 7. Mult Scler Relat Disord. 2023. PMID: 37068368 Free PMC article.
Correlation of disability with quality of life in patients with multiple sclerosis treated with natalizumab: primary results and post hoc analysis of the TYSabri ImPROvement study (PROTYS).
Achtnichts L, Zecca C, Findling O, Kamm CP, Mueller S, Kuhle J, Lutterotti A, Gobbi C, Viviani C, Villiger-Borter E, Nedeltchev K. Achtnichts L, et al. Among authors: kamm cp. BMJ Neurol Open. 2023 Jan 26;5(1):e000304. doi: 10.1136/bmjno-2022-000304. eCollection 2023. BMJ Neurol Open. 2023. PMID: 36727105 Free PMC article.
Correction: Swiss QUality of life and healthcare impact Assessment in a Real-world Erenumab treated migraine population (SQUARE study): interim results.
Gantenbein AR, Agosti R, Kamm CP, Landmann G, Meier N, Merki-Feld GS, Petersen JA, Pohl H, Ryvlin P, Schankin CJ, Viceic D, Zecca C, Schäfer E, Meyer I, Arzt ME. Gantenbein AR, et al. Among authors: kamm cp. J Headache Pain. 2022 Dec 19;23(1):161. doi: 10.1186/s10194-022-01530-9. J Headache Pain. 2022. PMID: 36536271 Free PMC article. No abstract available.
Factors associated with material deprivation in persons with multiple sclerosis in Switzerland: Cross-sectional data from the Swiss Multiple Sclerosis Registry.
Sanak L, Kamm CP, Chan A, Stanikić M, Manjaly ZM, Zecca C, Calabrese P, von Wyl V; Swiss Multiple Sclerosis Registry (SMSR). Sanak L, et al. Among authors: kamm cp. Mult Scler Relat Disord. 2023 Jan;69:104438. doi: 10.1016/j.msard.2022.104438. Epub 2022 Dec 5. Mult Scler Relat Disord. 2023. PMID: 36495844 Free article.
Swiss QUality of life and healthcare impact Assessment in a Real-world Erenumab treated migraine population (SQUARE study): interim results.
Gantenbein AR, Agosti R, Kamm CP, Landmann G, Meier N, Merki-Feld GS, Petersen JA, Pohl H, Ryvlin P, Schankin CJ, Viceic D, Zecca C, Schäfer E, Meyer I, Arzt ME. Gantenbein AR, et al. Among authors: kamm cp. J Headache Pain. 2022 Nov 18;23(1):142. doi: 10.1186/s10194-022-01515-8. J Headache Pain. 2022. PMID: 36401172 Free PMC article.
78 results